Commentary on “Is posttransplant lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma” by Giovanni Barosi and Robert Peter Gale

Sarah A Holstein, Vera J. Suman, Philip L. McCarthy

Research output: Contribution to journalComment/debate

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)565-566
Number of pages2
JournalLeukemia
Volume33
Issue number2
DOIs
StatePublished - Feb 1 2019

Fingerprint

Autografts
Standard of Care
Multiple Myeloma
lenalidomide

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Commentary on “Is posttransplant lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma” by Giovanni Barosi and Robert Peter Gale. / Holstein, Sarah A; Suman, Vera J.; McCarthy, Philip L.

In: Leukemia, Vol. 33, No. 2, 01.02.2019, p. 565-566.

Research output: Contribution to journalComment/debate

@article{85de218534bb4b45b95a7f13be941b0c,
title = "Commentary on “Is posttransplant lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma” by Giovanni Barosi and Robert Peter Gale",
author = "Holstein, {Sarah A} and Suman, {Vera J.} and McCarthy, {Philip L.}",
year = "2019",
month = "2",
day = "1",
doi = "10.1038/s41375-018-0359-7",
language = "English (US)",
volume = "33",
pages = "565--566",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Commentary on “Is posttransplant lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma” by Giovanni Barosi and Robert Peter Gale

AU - Holstein, Sarah A

AU - Suman, Vera J.

AU - McCarthy, Philip L.

PY - 2019/2/1

Y1 - 2019/2/1

UR - http://www.scopus.com/inward/record.url?scp=85059890615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059890615&partnerID=8YFLogxK

U2 - 10.1038/s41375-018-0359-7

DO - 10.1038/s41375-018-0359-7

M3 - Comment/debate

C2 - 30635635

AN - SCOPUS:85059890615

VL - 33

SP - 565

EP - 566

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 2

ER -